<p>卡地納健康（NYSE:CAH - 獲取免費報告）於週二發佈了季度收益數據。該公司報告本季度每股收益（EPS）為 2.08 美元，超出市場共識預期的 2.03 美元，超出幅度為 0.05 美元，Briefing.com 報道。卡地納健康的股本回報率為負的 68.84%，淨利潤率為 0.70%。該公司本季度的收入為 601.6 億美元，而市場共識預期為 609.1 億美元。在去年同期，該公司的每股收益為 1.84 美元。與去年同期相比，該公司的季度收入增長了 0.5%。卡地納健康更新了其 2026 財年的指引，預計每股收益在 9.300-9.500 之間。</p>
<p>獲取 <strong>卡地納健康</strong> 的提醒：</p>
<h2>卡地納健康股票表現</h2>
<ul>
<li>對市場感到懷疑？3 只股票幫助你渡過恐懼、不確定性和懷疑</li>
</ul>
<p>卡地納健康的股票週二開盤價為 158.07 美元。該股票的 50 日移動平均價為 160.10 美元，200 日移動平均價為 144.16 美元。該公司的市值為 377.3 億美元，市盈率為 24.66，PEG 比率為 1.56，貝塔值為 0.67。卡地納健康的 52 周低點為 100.07 美元，52 周高點為 168.44 美元。</p>
<h2>分析師評級上調與下調</h2>
<p>多位分析師對該公司進行了評估。富國銀行將卡地納健康的評級從 “持平” 上調至 “增持”，並在 6 月 3 日的研究報告中將其目標價從 136.00 美元提高至 179.00 美元。羅伯特·W·貝爾德將卡地納健康的目標價從 156.00 美元上調至 170.00 美元，並在 5 月 2 日的報告中給予該公司 “跑贏大盤” 的評級。摩根士丹利在週二的報告中重申了對卡地納健康股票的 “增持” 評級。瑞銀集團在週二的報告中重申了對卡地納健康股票的 “買入” 評級。最後，花旗集團在 6 月 13 日的研究報告中重申了 “中性” 評級，並將卡地納健康股票的目標價從 157.00 美元上調至 170.00 美元。三位研究分析師對該股票給予了持有評級，十二位分析師給予了買入評級。根據 MarketBeat 的數據，該股票目前的平均評級為 “適度買入”，共識目標價為 158.07 美元。</p>
<ul>
<li>醫療技術股票受益於急性護理需求上升</li>
</ul>
<p><strong>查看我們對卡地納健康的最新股票分析</strong></p>
<h2>對卡地納健康的對沖基金看法</h2>
<p>一家對沖基金最近增加了對卡地納健康股票的持股。Jones Financial Companies Lllp 在第一季度將其在卡地納健康（NYSE:CAH - 免費報告）股票中的持股比例提高了 198.3%，根據其最近向證券交易委員會的披露。該基金在本季度購買了額外的 14,034 股後，持有該公司 21,112 股股票。根據其最近的 SEC 文件，Jones Financial Companies Lllp 在卡地納健康的持股價值為 27,000 美元。對沖基金和其他機構投資者持有該公司 87.17% 的股票。</p>
<h2>關於卡地納健康</h2>
<p>（獲取免費報告）</p>
<ul>
<li>對於卡地納健康，證明將在其表現中體現</li>
</ul>
<p>卡地納健康公司在美國、加拿大、歐洲、亞洲及國際上運營，提供醫療服務和產品。它為醫院、醫療系統、藥房、門診手術中心、臨牀實驗室、醫生辦公室和家庭患者提供定製解決方案。</p>
<h2>閲讀更多</h2>
<ul>
<li>我們更看好的五隻股票超過卡地納健康</li>
<li>如何使用 MarketBeat Excel 股息計算器</li>
<li>MP 材料股票因稀土熱潮創下新高</li>
<li>什麼是股息競爭者？投資股息競爭者</li>
<li>AMD 為市場份額增長鋪平道路：股票反彈剛剛開始</li>
<li>股票評級和推薦：理解分析師評級</li>
<li>IBM：上次發生這種情況時，股票上漲了 35%</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/EarningsChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUNBSA?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/EarningsChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUNBSA"/></p>
<p><em>此即時新聞提醒由敍事科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快和最準確的報道。此故事在發佈前已由 MarketBeat 的編輯團隊審核。如對該故事有任何問題或意見，請發送至 contact@marketbeat.com.</em></p>
<h2>你現在應該投資 1,000 美元在卡地納健康嗎？</h2>
<p>在你考慮卡地納健康之前，你需要聽聽這個。</p>
<p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦的股票。MarketBeat 已識別出五隻頂級分析師正在悄悄向客户推薦的股票，以便在更廣泛的市場注意到之前購買……而卡地納健康並不在名單上。</p>
<p>雖然卡地納健康目前在分析師中獲得了適度買入評級，但頂級分析師認為這五隻股票更值得購買。</p>
<p>在這裏查看這五隻股票</p>

卡地納健康

<p>卡地納健康（NYSE:CAH）報告的季度每股收益為 2.08 美元，超出預期 0.05 美元。收入為 601.6 億美元，略低於預測的 609.1 億美元。該公司的淨利潤率為 0.70%，股本回報率為負的 68.84%。與去年同期相比，收入增長了 0.5%。卡地納健康更新了其 2026 財年的每股收益指引至 9.300-9.500。分析師普遍對該股票給予積極評級，目標價共識為 158.07 美元，大多數分析師建議買入</p>

<p>Cardinal Health (NYSE:CAH - Get Free Report) posted its quarterly earnings data on Tuesday. The company reported $2.08 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.03 by $0.05, Briefing.com reports. Cardinal Health had a negative return on equity of 68.84% and a net margin of 0.70%. The firm had revenue of $60.16 billion for the quarter, compared to the consensus estimate of $60.91 billion. During the same quarter in the previous year, the business earned $1.84 EPS. The company's quarterly revenue was up .5% compared to the same quarter last year. Cardinal Health updated its FY 2026 guidance to 9.300-9.500 EPS.</p>
<div class="lb-trans"><p>卡地納健康（NYSE:CAH - 獲取免費報告）於週二發佈了季度收益數據。該公司報告本季度每股收益（EPS）為 2.08 美元，超出市場共識預期的 2.03 美元，超出幅度為 0.05 美元，Briefing.com 報道。卡地納健康的股本回報率為負的 68.84%，淨利潤率為 0.70%。該公司本季度的收入為 601.6 億美元，而市場共識預期為 609.1 億美元。在去年同期，該公司的每股收益為 1.84 美元。與去年同期相比，該公司的季度收入增長了 0.5%。卡地納健康更新了其 2026 財年的指引，預計每股收益在 9.300-9.500 之間。</p>
</div><p>Get <strong>Cardinal Health</strong> alerts:</p>
<div class="lb-trans"><p>獲取 <strong>卡地納健康</strong> 的提醒：</p>
</div><h2>Cardinal Health Stock Performance</h2>
<div class="lb-trans"><h2>卡地納健康股票表現</h2>
</div><ul>
<li>Doubt the Market? 3 Stocks to Rideout Fear, Uncertainty and Doubt</li>
</ul>
<div class="lb-trans"><ul>
<li>對市場感到懷疑？3 只股票幫助你渡過恐懼、不確定性和懷疑</li>
</ul>
</div><p>Cardinal Health stock opened at $158.07 on Tuesday. The stock has a fifty day moving average of $160.10 and a two-hundred day moving average of $144.16. The company has a market capitalization of $37.73 billion, a price-to-earnings ratio of 24.66, a PEG ratio of 1.56 and a beta of 0.67. Cardinal Health has a fifty-two week low of $100.07 and a fifty-two week high of $168.44.</p>
<div class="lb-trans"><p>卡地納健康的股票週二開盤價為 158.07 美元。該股票的 50 日移動平均價為 160.10 美元，200 日移動平均價為 144.16 美元。該公司的市值為 377.3 億美元，市盈率為 24.66，PEG 比率為 1.56，貝塔值為 0.67。卡地納健康的 52 周低點為 100.07 美元，52 周高點為 168.44 美元。</p>
</div><h2>Analyst Upgrades and Downgrades</h2>
<div class="lb-trans"><h2>分析師評級上調與下調</h2>
</div><p>A number of analysts have weighed in on the company. Wells Fargo &amp; Company raised Cardinal Health from an &#34;equal weight&#34; rating to an &#34;overweight&#34; rating and increased their price objective for the stock from $136.00 to $179.00 in a research report on Tuesday, June 3rd. Robert W. Baird raised their price target on Cardinal Health from $156.00 to $170.00 and gave the company an &#34;outperform&#34; rating in a report on Friday, May 2nd. Morgan Stanley reissued an &#34;overweight&#34; rating on shares of Cardinal Health in a report on Tuesday. UBS Group reissued a &#34;buy&#34; rating on shares of Cardinal Health in a report on Tuesday. Finally, Citigroup reaffirmed a &#34;neutral&#34; rating and issued a $170.00 price objective (up from $157.00) on shares of Cardinal Health in a research note on Friday, June 13th. Three research analysts have rated the stock with a hold rating and twelve have issued a buy rating to the stock. According to MarketBeat, the stock currently has an average rating of &#34;Moderate Buy&#34; and a consensus target price of $158.07.</p>
<div class="lb-trans"><p>多位分析師對該公司進行了評估。富國銀行將卡地納健康的評級從 “持平” 上調至 “增持”，並在 6 月 3 日的研究報告中將其目標價從 136.00 美元提高至 179.00 美元。羅伯特·W·貝爾德將卡地納健康的目標價從 156.00 美元上調至 170.00 美元，並在 5 月 2 日的報告中給予該公司 “跑贏大盤” 的評級。摩根士丹利在週二的報告中重申了對卡地納健康股票的 “增持” 評級。瑞銀集團在週二的報告中重申了對卡地納健康股票的 “買入” 評級。最後，花旗集團在 6 月 13 日的研究報告中重申了 “中性” 評級，並將卡地納健康股票的目標價從 157.00 美元上調至 170.00 美元。三位研究分析師對該股票給予了持有評級，十二位分析師給予了買入評級。根據 MarketBeat 的數據，該股票目前的平均評級為 “適度買入”，共識目標價為 158.07 美元。</p>
</div><ul>
<li>Medical Technology Stock Benefits from Rising Acute Care Demand</li>
</ul>
<div class="lb-trans"><ul>
<li>醫療技術股票受益於急性護理需求上升</li>
</ul>
</div><p><strong>Check Out Our Latest Stock Analysis on Cardinal Health</strong></p>
<div class="lb-trans"><p><strong>查看我們對卡地納健康的最新股票分析</strong></p>
</div><h2>Hedge Funds Weigh In On Cardinal Health</h2>
<div class="lb-trans"><h2>對卡地納健康的對沖基金看法</h2>
</div><p>A hedge fund recently raised its stake in Cardinal Health stock. Jones Financial Companies Lllp lifted its holdings in shares of Cardinal Health, Inc. (NYSE:CAH - Free Report) by 198.3% during the 1st quarter, according to its most recent disclosure with the Securities &amp; Exchange Commission. The fund owned 21,112 shares of the company's stock after purchasing an additional 14,034 shares during the quarter. Jones Financial Companies Lllp's holdings in Cardinal Health were worth $27,000 as of its most recent SEC filing. Hedge funds and other institutional investors own 87.17% of the company's stock.</p>
<div class="lb-trans"><p>一家對沖基金最近增加了對卡地納健康股票的持股。Jones Financial Companies Lllp 在第一季度將其在卡地納健康（NYSE:CAH - 免費報告）股票中的持股比例提高了 198.3%，根據其最近向證券交易委員會的披露。該基金在本季度購買了額外的 14,034 股後，持有該公司 21,112 股股票。根據其最近的 SEC 文件，Jones Financial Companies Lllp 在卡地納健康的持股價值為 27,000 美元。對沖基金和其他機構投資者持有該公司 87.17% 的股票。</p>
</div><h2>About Cardinal Health</h2>
<div class="lb-trans"><h2>關於卡地納健康</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（獲取免費報告）</p>
</div><ul>
<li>For Cardinal Health, the Proof Will be in Its Performance</li>
</ul>
<div class="lb-trans"><ul>
<li>對於卡地納健康，證明將在其表現中體現</li>
</ul>
</div><p>Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.</p>
<div class="lb-trans"><p>卡地納健康公司在美國、加拿大、歐洲、亞洲及國際上運營，提供醫療服務和產品。它為醫院、醫療系統、藥房、門診手術中心、臨牀實驗室、醫生辦公室和家庭患者提供定製解決方案。</p>
</div><h2>Read More</h2>
<div class="lb-trans"><h2>閲讀更多</h2>
</div><ul>
<li>Five stocks we like better than Cardinal Health</li>
<li>How to Use the MarketBeat Excel Dividend Calculator</li>
<li>MP Materials Stock Rides Rare Earth Boom to New Highs</li>
<li>What Are Dividend Contenders? Investing in Dividend Contenders</li>
<li>AMD Paves Path for Market Share Gains: Stock Rally Has Just Begun</li>
<li>Stock Ratings and Recommendations: Understanding Analyst Ratings</li>
<li>IBM: The Last Time This Happened, the Stock Rallied 35%</li>
</ul>
<div class="lb-trans"><ul>
<li>我們更看好的五隻股票超過卡地納健康</li>
<li>如何使用 MarketBeat Excel 股息計算器</li>
<li>MP 材料股票因稀土熱潮創下新高</li>
<li>什麼是股息競爭者？投資股息競爭者</li>
<li>AMD 為市場份額增長鋪平道路：股票反彈剛剛開始</li>
<li>股票評級和推薦：理解分析師評級</li>
<li>IBM：上次發生這種情況時，股票上漲了 35%</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/EarningsChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUNBSA" alt="" original-src="https://www.marketbeat.com/scripts/EarningsChart.ashx?Prefix=NYSE&amp;Symbol=CAH"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即時新聞提醒由敍事科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快和最準確的報道。此故事在發佈前已由 MarketBeat 的編輯團隊審核。如對該故事有任何問題或意見，請發送至 contact@marketbeat.com.</em></p>
</div><h2>Should You Invest $1,000 in Cardinal Health Right Now?</h2>
<div class="lb-trans"><h2>你現在應該投資 1,000 美元在卡地納健康嗎？</h2>
</div><p>Before you consider Cardinal Health, you'll want to hear this.</p>
<div class="lb-trans"><p>在你考慮卡地納健康之前，你需要聽聽這個。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cardinal Health wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦的股票。MarketBeat 已識別出五隻頂級分析師正在悄悄向客户推薦的股票，以便在更廣泛的市場注意到之前購買……而卡地納健康並不在名單上。</p>
</div><p>While Cardinal Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>雖然卡地納健康目前在分析師中獲得了適度買入評級，但頂級分析師認為這五隻股票更值得購買。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在這裏查看這五隻股票</p>
</div>

卡地納健康（NYSE:CAH）公佈季度財報，每股收益超出預期 0.05 美元